Meetings with Marcus Powlowski reported by registered lobbyists. Lobbyists must report every oral, arranged meeting with an MP, minister or other designated public office holder.
Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes.Read more
Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes.Read more
Access to medication - expanding the range of medications covered by various insurance plans, and the number of Canadians able to access and afford medication. This includes a national pharmaceutical strategy.Read more
Canadian Institutes of Health Research as it relates to continued federal funding & long term investment in health research.
Advocate for federal action on the Health Human Resources (HHR) crisis by delivering a Pan-Canadian strategy that addresses recruitment, retention, and other key issues.Read more
Bringing attention to OHA's Pre Budget Submission which includes the following:
Recommendation 1: Position Canada as a global leader in the health research industry by strengthening talent pipelines, sustaining funding, and leveraging diversity.
Recommendation 2: Bolster Canada’s competitiveness by accelerating health research commercialization through regulatory modernization, infrastructure investment, and federal-provincial partnerships.
Jordan's Principle regulation and funding. Qualitative and quantitative study of speech, language and hearing for First Nations, Inuit and Metis populations. Seeking funding for Qualitative and quantitative sstudy of speech, language and hearing for First Nations, Inuit and Metis populations. Source of funding to be determined.Read more
Advocating for the next round of Strategic Science Fund (SSF) funding to explicitly prioritize research, innovation, and implementation initiatives that advance children’s health, with a special emphasis on brain health and neurodevelopmental disabilities (NDD).Read more
Matthew Pollesel · Director of Parliamentary Affairs and Issues Management, Health Canada (HC)
David Lee · Chief Regulatory Officer, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Working with federal partners to streamline Health Canada policies and processes related to clinical trials and drug authorization specific to children.Read more
Supporting the introduction and passing of legislation that would increase protections for children and youth online.
Access to medication - expanding the range of medications covered by various insurance plans, and the number of Canadians able to access and afford medication. This includes a national pharmaceutical strategy.Read more
Advocating spending priorities related to the dissemination of Canada's Official Development Assistance envelope to ensure that aid is targetted at initiatives that serve the world's poorest.Read more
Advocating for increased investment toward tuberculosis elimination, specifically through the creation of a national tuberculosis elimination strategy.
Increases to the International Assistance Envelope
Allocations of the International Assistance Envelope
Economic Development: lobbying activity will include briefings, presentations and discussions associated with the Industrial and Technological Benefits (ITB) policy as it relates to defence and civil security programs. The ITB policy is a key evaluated component of many of the federal government programs that Saab competes in, and as such information on the means through which the company aims to address its ITB obligations is worthy of discussion with the relevant government authorities.Read more
Defence: lobbying activities will include discussions, briefing and presentations on Defence and Civil Security related programs. These include, but are not limited to, aerospace programs, maritime/naval programs, land domain programs, training and simulation programs, research and development and civil security related activities
The RCMP's core responsibilities, Federal Policing, Contract and Indigenous Policing and Specialized Policing Services, in respect to promoting investments, resources, modernization and contract renewals.Read more
William Fassett · Chief of Staff, House of Commons
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing.Read more
The CHC supports the establishment of a national pharmcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.
